Evaluating Patient Reported Outcomes in Radiation Therapy, the PRO-RT Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

18 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-03-02

Study Completion Date

2023-04-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study explores the use of the Hugo platform to involve study participants in their healthcare and treatments. The Hugo platform may allow researchers to collect better and more accurate real-time health data, from other clinics/hospitals, pharmacies and other electronic devices. The purpose of this research is to see if the use of the Hugo platform is consistent, accurate, cost effective, and time efficient, as it collects and transmits important real-time health information from other clinics/hospitals, pharmacies, and other electronic devices.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Remote Monitoring of Patient Reported Outcomes to Improve the Efficacy of the Acute Phase Radiotherapy Review Process

NCT06274892

Prostate Cancer Breast Cancer

RECRUITING NA

Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study

NCT02457962

Solid Tumors Hematologic Malignancies

ACTIVE_NOT_RECRUITING

Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma

NCT06014827

Lung Non-Small Cell Carcinoma Stage IV Lung Cancer AJCC v8

RECRUITING PHASE2

Phase I Study of Accelerated Hypofractionated Image-Guided Radiation Therapy

NCT03623334

Non-small Cell Lung Cancer

COMPLETED NA

Feasibility, Safety, and Efficacy of Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Central Lung Tumors

NCT05609331

Lung Cancer

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. Evaluate the data aggregation from a patient centered platform over a follow up period for completeness and quality, including externally linked electronic health record (EHR) information, toxicity completion, and the patient reported outcomes (PRO) response rates for study patients, compared with historical pre-coronavirus disease (COVID) cohort of registry patients.

II. To explore biometric information obtained from wearables as it pertains to the toxicity of treatment for patients using a wearable device.

III. To estimate app-based survey completion rates using Hugo-based survey incentive completion (gift cards).

IV. To explore the cost data available on the platform.

OUTLINE:

Patients complete surveys via the Hugo Platform at baseline (before treatment), after treatment, and at 3 and 6 months after treatment. Patients' medical records and Fitbit information are also collected into the Hugo Platform.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Carcinoma Head and Neck Carcinoma Lung Carcinoma Malignant Solid Neoplasm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observational (surveys, medical records & Fitbit collection)

Patients complete surveys via the Hugo Platform at baseline (before treatment), after treatment, and at 3 and 6 months after treatment. Patients' medical records and Fitbit information are also collected into the Hugo Platform.

Electronic Health Record Review

Intervention Type OTHER

Medical records are collected

Medical Device Usage and Evaluation

Intervention Type OTHER

Fitbit information is collected

Survey Administration

Intervention Type OTHER

Complete surveys

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electronic Health Record Review

Medical records are collected

Intervention Type OTHER

Medical Device Usage and Evaluation

Fitbit information is collected

Intervention Type OTHER

Survey Administration

Complete surveys

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18+
* English speaking
* Consented for Outcomes Registry Study (15-000136)
* Undergoing radiotherapy for cancer treatment with curative intent
* Willing to and able to give consent and participate in study
* Willing to complete all surveys
* Able to access a device (computer, smartphone, or tablet) with web access every day to complete study surveys
* Willing to connect to a device (i.e., a smartphone, Fitbit, or tablet) that can regularly link to Hugo for data transfer
* Willing to share personal information to Tremendous to be able to obtain the Visa e-cards for time and effort put into this study
* Willing to use the Hugo health data sharing platform
* Willing to create a Mayo Clinic Patient Portal (if not already created)

Exclusion Criteria

* Unable to give consent and enroll prior to administration of baseline survey
* Partial breast radiation therapy (RT) (3 fraction), due to overlap in cadence used for all disease sites
* Stereotactic body radiation therapy (SBRT) to the lung, due to overlap in cadence used for all disease sites
* Co-enrollment on another PRO related study (soft rule)

* Coordinator would need to get source data from Adam via Hugo
* Response data will only be accessible by select people

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No